English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 17 July 2020, 12:00 HKT/SGT
Share:
    

Source: Cariflex PTE. Ltd.
Cariflex to Double its Polyisoprene Latex Capacity at the Paulinia Facility in Brazil
- Cariflex Board of Directors approved the approximate $50 million capital project in April 2020
- The new plant is expected to be operational in the first quarter of 2021

SINGAPORE, July 17, 2020 - (ACN Newswire) - Cariflex PTE. Ltd. (Cariflex) today announced that it will be constructing a new large-scale polyisoprene latex plant at its Paulinia, Brazil, facility to meet the strong market demand from its medical and consumer product customers.




"Cariflex is excited to be making a sizeable investment in the growth of the polyisoprene latex business. Cariflex polyisoprene latex is a unique synthetic alternative to natural rubber latex for dipped goods and various specialty products. With the current strong demand for medical protective equipment such as surgical gloves, we recognize our customers' needs to have more material available," said Philippe Henderson, Cariflex Sales & Marketing leader.

With Cariflex's increased production capacity and unmatched global service network, its customers can be assured of secure supplies anywhere in the world. Following the addition of this polyisoprene latex unit, the new resulting capacity in Paulinia, Brazil, combined with the existing capacity in Himeji, Japan, will strengthen Cariflex's position as the global leader of polyisoprene latex with unmatched quality and supply diversity. Customers will benefit from Cariflex IR0401 latex volumes sourced from four distinct production lines.

The addition of this new production line is replicating the technology of the current fully utilized unit and will double the polyisoprene latex capacity of the site.

Daelim Industrial Co., Ltd named Prakash Kolluri as Chief Executive Officer of Cariflex Pte Ltd, for the global business. Sean Kim, Chief Executive Officer for Daelim Industrial Co., Ltd, said, "We are delighted to have appointed Mr. Prakash Kolluri who is a huge asset to the company. We are confident Prakash will move Cariflex Pte Ltd forward and bring a wealth of experience which will be extremely valuable in driving our future growth globally."

"Our strategic decision of capacity expansion, in support of organic growth, separates us from competition. Our industry-leading polyisoprene latex capacity acts as a catalyst for our valued customer base to make inroads in new geographies. Cariflex is strategically positioned and has a bright future serving medical and other high-value markets," Prakash Kolluri, Chief Executive Officer mentioned.

ABOUT Cariflex

Cariflex is a global leader of isoprene rubber latex ("IR Latex") and isoprene rubber ("IR") for medical end markets and other high-value markets with strong growth drivers. Cariflex produces high value-added synthetic rubbers and latexes used for medical materials such as surgical gloves and rubber stoppers and seals for drug delivery devices. Cariflex is a wholly owned subsidiary of Daelim Industrial Co., Ltd.

For Press Inquiries
Sang-woo Ryu, Cariflex: [email protected]
Eric Byun, KorCom Porter Novelli (Daelim Industrial's PR agency): [email protected]

Topic: Increase Production
Source: Cariflex PTE. Ltd.

Sectors: Healthcare & Pharm, Construct, Engineering
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Toyota Gazoo Racing Hyped For Hypercar Debut  
Apr 23, 2021 16:02 HKT/SGT
Moonstake Hosts Joint Interview with CEO of Trusted Ranking Platform Staking Rewards, Mirkos Schmiedl  
Apr 23, 2021 15:00 HKT/SGT
Pertama Digital expresses interest to apply for BNM's digital banking license, currently in talks to form dedicated consortium  
Apr 23, 2021 15:00 HKT/SGT
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally  
Apr 23, 2021 14:06 HKT/SGT
Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body Cancer in Japan  
Apr 23, 2021 13:55 HKT/SGT
UN youth envoy to open volunteer conference supporting Habitat for Humanity's COVID-19 response   
Apr 23, 2021 12:35 HKT/SGT
Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies  
Apr 23, 2021 12:02 HKT/SGT
NEC, UN-Habitat and Peace Winds Japan provide thermography camera in Kenya to prevent the spread of COVID-19  
Apr 23, 2021 09:16 HKT/SGT
Annual Report on Form 20-F for Fiscal Year 2020 of Aluminum Corporation of China Limited Now Available  
Apr 23, 2021 08:46 HKT/SGT
Notice Regarding Biogen's Disclosure About the Submission of Marketing Authorization Applications in Brazil, Canada, Australia, and Switzerland for Aducanumab for Alzheimer's Disease  
Apr 23, 2021 08:07 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575